Streetbeat News

Price Targets

IMMP

Baird analyst Joel Beatty has reiterated his 'Outperform' rating on Immutep (NASDAQ:IMMP) and maintained a $7 price target.

Portfolio Pulse from richadhand@benzinga.com

August 28, 2023 | 1:45 pm

HIBB

Baird analyst Peter Benedict maintains an Outperform rating on Hibbett (NASDAQ:HIBB) and raises the price target from $50 to $56.

Portfolio Pulse from richadhand@benzinga.com

August 28, 2023 | 1:42 pm

BRZE

DA Davidson analyst Gil Luria has reiterated a Neutral rating on Braze (NASDAQ:BRZE) and maintained a $35 price target.

Portfolio Pulse from richadhand@benzinga.com

August 28, 2023 | 1:41 pm

RC

B. Riley Securities analyst Matt Howlett has reiterated a 'Buy' rating on Ready Capital (NYSE:RC) and maintained a price target of $13.

Portfolio Pulse from richadhand@benzinga.com

August 28, 2023 | 1:39 pm

HIBB

B. Riley Securities analyst Anna Glaessgen maintains a Neutral rating on Hibbett (NASDAQ:HIBB) and raises the price target from $37 to $45.

Portfolio Pulse from richadhand@benzinga.com

August 28, 2023 | 1:38 pm

VALN

HC Wainwright & Co. analyst Edward White has reiterated a 'Buy' rating on Valneva (NASDAQ:VALN) and maintained a $22 price target.

Portfolio Pulse from richadhand@benzinga.com

August 28, 2023 | 1:36 pm

ETNB

UBS analyst Eliana Merle has initiated coverage on 89bio (NASDAQ:ETNB) with a Buy rating and a price target of $36.

Portfolio Pulse from richadhand@benzinga.com

August 28, 2023 | 1:34 pm

AKRO

UBS analyst Eliana Merle has initiated coverage on Akero Therapeutics (NASDAQ:AKRO) with a Buy rating and a price target of $83.

Portfolio Pulse from richadhand@benzinga.com

August 28, 2023 | 1:34 pm

XERS

Craig-Hallum analyst Robin Garner has initiated coverage on Xeris Biopharma Holdings (NASDAQ:XERS) with a Buy rating and a price target of $4.5.

Portfolio Pulse from richadhand@benzinga.com

August 28, 2023 | 1:32 pm

IRTC

Canaccord Genuity analyst William Plovanic has maintained a 'Buy' rating on iRhythm Technologies (NASDAQ:IRTC), but lowered the price target from $136 to $116.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 1:20 pm